US2466420A
(en)
|
1947-11-26 |
1949-04-05 |
Eastman Kodak Co |
Ketene condensation products with aldehydes
|
US3226394A
(en)
|
1964-06-16 |
1965-12-28 |
Shulton Inc |
Pyridylethylated anthranilamides and derivatives thereof
|
CH504416A
(de)
|
1966-12-05 |
1971-03-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
|
US4551540A
(en)
|
1983-01-17 |
1985-11-05 |
Borg-Warner Chemicals, Inc. |
Substituted 2,5-dimethylpyrroles
|
US5190541A
(en)
|
1990-10-17 |
1993-03-02 |
Boston Scientific Corporation |
Surgical instrument and method
|
DE69332948T2
(de)
|
1992-03-05 |
2003-11-27 |
Univ Texas |
Verwendung von Immunokonjugate zur Diagnose und/oder Therapie der vaskularisierten Tumoren
|
US5474765A
(en)
|
1992-03-23 |
1995-12-12 |
Ut Sw Medical Ctr At Dallas |
Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
|
US5686472A
(en)
|
1992-10-29 |
1997-11-11 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5593992A
(en)
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
JPH10507185A
(ja)
|
1994-10-14 |
1998-07-14 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
2−(イミダゾール−4−イル)カルバペネム誘導体、その中間体および抗菌剤としての使用
|
CA2216943C
(en)
|
1995-04-19 |
2003-06-17 |
Schneider (Usa) Inc. |
Drug release coated stent
|
US6117432A
(en)
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
TW349948B
(en)
|
1995-10-31 |
1999-01-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 2-quinolone derivatives
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
IL123568A
(en)
|
1995-12-08 |
2001-08-08 |
Janssen Pharmaceutica Nv |
History (Imidazole - 5Il) Methyl-2-quinolinone inhibitors of Prenzyl transferase, their preparation, pharmaceutical preparations containing them and their preparation and drugs containing them
|
US5874442A
(en)
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US5702390A
(en)
|
1996-03-12 |
1997-12-30 |
Ethicon Endo-Surgery, Inc. |
Bioplar cutting and coagulation instrument
|
JPH11514676A
(ja)
|
1996-08-09 |
1999-12-14 |
メルク エンド カンパニー インコーポレーテッド |
立体選択的脱酸素化反応
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
JP2001505548A
(ja)
|
1996-12-20 |
2001-04-24 |
トヴァリシェストヴォ エス オグラニチェンノイ オトヴェトストヴェンノストジュ“タブジュファーム” |
凍結乾燥ハイドロクロライド−1β,10β−エポキシ−13−ジメチルアミノ−グアヤ−3(4)−エン−6,12−オリドの生成方法および装置
|
TW591030B
(en)
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
WO1998049157A1
(en)
|
1997-04-25 |
1998-11-05 |
Janssen Pharmaceutica N.V. |
Farnesyltransferase inhibiting quinazolinones
|
TW491872B
(en)
|
1997-05-27 |
2002-06-21 |
Ciba Sc Holding Ag |
Block oligomers containing l-hydrocarbyloxy-2,2,6,6-tetramethyl-4- piperidyl groups as stabilizers for lower polyolefin
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
HU228537B1
(en)
|
1998-03-05 |
2013-03-28 |
Formula One Man Ltd |
Data communication system
|
US6303654B1
(en)
|
1998-03-12 |
2001-10-16 |
Wisconsin Alumni Research Foundation |
Acyclic monoterpenoid derivatives
|
AU5086499A
(en)
|
1998-07-01 |
2000-01-24 |
Merck & Co., Inc. |
Process for making farnesyl-protein transferase inhibitors
|
JP2002520324A
(ja)
|
1998-07-10 |
2002-07-09 |
メルク エンド カムパニー インコーポレーテッド |
新規な血管形成インヒビター
|
ID27562A
(id)
|
1998-08-27 |
2001-04-12 |
Pfizer Prod Inc |
Turunan-turunan kinolin-2-ona tersubstitusi alkunil yang berguna sebagai zat anti kanker
|
ATE289602T1
(de)
|
1998-08-27 |
2005-03-15 |
Pfizer Prod Inc |
Quinolin-2-on-derivate verwendbar als antikrebsmittel
|
GB9824579D0
(en)
|
1998-11-10 |
1999-01-06 |
Novartis Ag |
Organic compounds
|
PT1140935E
(pt)
|
1998-12-23 |
2003-10-31 |
Janssen Pharmaceutica Nv |
Derivados da quinolina 1,2-ciclizada
|
DK1140938T3
(da)
|
1999-01-11 |
2003-12-22 |
Univ Princeton |
Højaffinitetsinhibitorer for målvalidering og anvendelser heraf
|
KR100710100B1
(ko)
|
1999-04-15 |
2007-04-23 |
브리스톨-마이어스스퀴브컴파니 |
환형 단백질 티로신 키나제 억제제
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
ES2223705T3
(es)
|
1999-04-28 |
2005-03-01 |
Board Of Regents, The University Of Texas System |
Composiciones y metodos para el tratamiento de cancer mediante inhibi cion selectiva del vegf.
|
US6346625B1
(en)
|
1999-06-23 |
2002-02-12 |
Astrazeneca Ab |
Protein kinase inhibitors
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
DE60043397D1
(de)
|
1999-12-28 |
2010-01-07 |
Pharmacopeia Inc |
Cytokine, insbesondere tnf-alpha, hemmer
|
FR2803592A1
(fr)
|
2000-01-06 |
2001-07-13 |
Aventis Cropscience Sa |
Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
|
US6558385B1
(en)
|
2000-09-22 |
2003-05-06 |
Tissuelink Medical, Inc. |
Fluid-assisted medical device
|
US6692491B1
(en)
|
2000-03-24 |
2004-02-17 |
Scimed Life Systems, Inc. |
Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
DE60113286T2
(de)
|
2000-10-17 |
2006-06-22 |
Merck & Co., Inc. |
Oral aktive salze mit tyrosinkinaseaktivität
|
US6958243B2
(en)
*
|
2000-12-14 |
2005-10-25 |
Biotage Ab |
Organic reactions with CO generating materials
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
US7101884B2
(en)
|
2001-09-14 |
2006-09-05 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO2003024931A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TWI259081B
(en)
|
2001-10-26 |
2006-08-01 |
Sugen Inc |
Treatment of acute myeloid leukemia with indolinone compounds
|
ATE335490T1
(de)
|
2001-10-30 |
2006-09-15 |
Novartis Pharma Gmbh |
Staurosporin-derivate als hemmer der flt3- rezeptor-tyrosinkinase-wirkung
|
HUP0500111A3
(en)
|
2001-12-27 |
2009-10-28 |
Theravance |
Indolinone derivatives useful as protein kinase inhibitors
|
GB2392154B
(en)
|
2002-05-23 |
2005-01-19 |
Cytopia Pty Ltd |
Protein Kinase Inhibitors
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
RU2005106871A
(ru)
|
2002-08-14 |
2005-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Ингибиторы протеинкиназ и их применение
|
WO2004018419A2
(en)
|
2002-08-23 |
2004-03-04 |
Chiron Corporation |
Benzimidazole quinolinones and uses thereof
|
AU2003258491A1
(en)
|
2002-09-05 |
2004-03-29 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
EP1549614A4
(en)
|
2002-10-03 |
2008-04-16 |
Targegen Inc |
VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION
|
WO2004039782A1
(ja)
|
2002-10-29 |
2004-05-13 |
Kirin Beer Kabushiki Kaisha |
Flt3自己リン酸化を阻害するキノリン誘導体およびキナゾリン誘導体並びにそれらを含有する医薬組成物
|
BR0316229A
(pt)
|
2002-11-13 |
2005-10-04 |
Chiron Corp |
Métodos de tratamento de câncer e métodos relacionados
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
WO2004058749A1
(en)
|
2002-12-18 |
2004-07-15 |
Vertex Pharmaceuticals Incorporated |
Benzisoxazole derivatives useful as inhibitors of protein kinases
|
BRPI0409136A
(pt)
|
2003-04-09 |
2006-04-25 |
Japan Tobacco Inc |
composto heteroaromático pentacìclico e uso medicinal do mesmo
|
US20050113566A1
(en)
|
2003-04-25 |
2005-05-26 |
Player Mark R. |
Inhibitors of C-FMS kinase
|
US7427683B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
c-fms kinase inhibitors
|
CA2536964A1
(en)
|
2003-04-25 |
2004-11-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
C-fms kinase inhibitors
|
US7790724B2
(en)
|
2003-04-25 |
2010-09-07 |
Janssen Pharmaceutica N.V. |
c-fms kinase inhibitors
|
CN1856461A
(zh)
|
2003-07-28 |
2006-11-01 |
史密丝克莱恩比彻姆公司 |
作为雌激素受体调节剂的亚环烷基化合物
|
BRPI0415467A
(pt)
|
2003-10-23 |
2006-12-19 |
Ab Science |
compostos de 2-aminoariloxazol para o tratamento de doenças
|
GB0326601D0
(en)
|
2003-11-14 |
2003-12-17 |
Novartis Ag |
Organic compounds
|
NZ548884A
(en)
|
2004-01-30 |
2010-06-25 |
Ab Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
EA013250B1
(ru)
|
2004-10-22 |
2010-04-30 |
Янссен Фармацевтика, Н.В. |
Ингибиторы c-fms киназы
|
WO2006047504A1
(en)
|
2004-10-22 |
2006-05-04 |
Janssen Pharmaceutica, N.V. |
Aromatic amides as inhibitors of c-fms kinase
|
NZ555289A
(en)
|
2004-10-22 |
2010-10-29 |
Janssen Pharmaceutica Nv |
Inhibitors of c-fms kinase
|
US7645755B2
(en)
|
2004-10-22 |
2010-01-12 |
Janssen Pharmaceutical N.V. |
Inhibitors of c-fms kinase
|
US20060281755A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
US20060281771A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
|
US20060281700A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
US20060281788A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
|
US20060281769A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
|
US7795279B2
(en)
|
2005-10-18 |
2010-09-14 |
Janssen Pharmaceutica Nv |
Method of inhibiting FLT3 kinase
|
CA2649919C
(en)
|
2006-04-20 |
2019-06-18 |
Janssen Pharmaceutica N.V. |
Phenyl-or pyridinyl amides as inhibitors of protein tyrosine kinases
|
US8697716B2
(en)
|
2006-04-20 |
2014-04-15 |
Janssen Pharmaceutica Nv |
Method of inhibiting C-KIT kinase
|
JP5089681B2
(ja)
|
2006-04-20 |
2012-12-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
c−fmsキナーゼの阻害剤としての複素環式化合物
|
EP2016074B1
(en)
|
2006-04-20 |
2016-01-13 |
Janssen Pharmaceutica N.V. |
Inhibitors of c-fms kinase
|
CA2672960A1
(en)
*
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
WO2008138184A1
(fr)
*
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
JO3240B1
(ar)
|
2007-10-17 |
2018-03-08 |
Janssen Pharmaceutica Nv |
c-fms مثبطات كيناز
|
AU2008318656A1
(en)
|
2007-10-31 |
2009-05-07 |
Janssen Pharmaceutica N.V. |
Biomarker for assessing response to FMS treatment
|
CA2748274A1
(en)
*
|
2008-12-30 |
2010-07-08 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as raf kinase inhibitors
|
JP2011026305A
(ja)
*
|
2009-06-24 |
2011-02-10 |
Daiichi Sankyo Co Ltd |
イミダゾールカルボニル化合物を含有する医薬組成物
|
SG10201405049RA
(en)
*
|
2009-09-28 |
2014-10-30 |
Hoffmann La Roche |
Benzoxazepin pi3k inhibitor compounds and methods of use
|
WO2011090935A1
(en)
*
|
2010-01-19 |
2011-07-28 |
Merck Sharp & Dohme Corp. |
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
|
EP2882757B1
(en)
*
|
2012-08-07 |
2016-10-05 |
Janssen Pharmaceutica, N.V. |
Process for the preparation of heterocyclic ester derivatives
|